Quote | Bristol-Myers Squibb Company (NYSE:BMY)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | Bristol-Myers Squibb Company (NYSE:BMY)
2023-06-09 09:26:24 ET The Biden administration on Friday published a list of Medicare Part B drugs that will be subject to inflation penalties for Q3 2023, including some of the products from AbbVie ( NYSE: ABBV ) and Amgen ( NASDAQ: AMGN ) in the list of 43 medications. ...
2023-06-08 23:21:36 ET Summary The article analyzes Amgen's financial performance, including balance sheet trends, valuation models, and competition & margin trends. We'll discuss AMGN's dividend and free cash flow of this large, very well-covered dividend growth stock. Am...
Message Board Posts | Bristol-Myers Squibb Company (NYSE:BMY)
|whytestocks: $BMY News Article - U.S. FDA Accepts for Priority Review Supplemental Biologics License||whytestocks||investorshangout||05/01/2023 6:30:47 PM|
|whytestocks: $BMY News Article - Bristol Myers Squibb's TRANSCEND FL and TRANSCEND NHL 001 Studies o||whytestocks||investorshangout||05/01/2023 6:25:58 PM|
|$BMY 1Q23 CC transcript:||DewDiligence||investorshub||04/28/2023 1:04:44 PM|
|$BMY 1Q23 results||DewDiligence||investorshub||04/27/2023 11:56:28 AM|
|$BMYs$ CCO, Christopher Boerner>CEO effective 11/1/23:||DewDiligence||investorshub||04/26/2023 8:43:15 PM|